PDCD1 Gene Complete Identifier and Functional Mapping Reference
Provide a comprehensive cross-database identifier and functional mapping reference for human PDCD1. This should serve as a definitive lookup resource …
Provide a comprehensive cross-database identifier and functional mapping reference for human PDCD1. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section
Structured Data Sources
This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 36 biological databases.
Further analyze this answer or run your own queries with BioBTree MCP.
alphafold, alphamissense, bgee, bgee_evidence, ccds, cellphonedb, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, msigdb, orphanet, ortholog, pdb, pharmgkb_gene, reactome, refseq, scxa, signor, spliceai, string_interaction, transcript, uniprotView API calls (48)
- search(PDCD1) https://sugi.bio/biobtree/api/search?i=PDCD1
- search(PDCD1, hgnc) https://sugi.bio/biobtree/api/search?i=PDCD1&s=hgnc
- search(PDCD1, ensembl) https://sugi.bio/biobtree/api/search?i=PDCD1&s=ensembl
- entry(HGNC:8760, hgnc) https://sugi.bio/biobtree/api/entry?i=HGNC%3A8760&s=hgnc
- entry(ENSG00000188389, ensembl) https://sugi.bio/biobtree/api/entry?i=ENSG00000188389&s=ensembl
- map(HGNC:8760, >>hgnc>>entrez) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Eentrez
- map(HGNC:8760, >>hgnc>>mim) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Emim
- map(ENSG00000188389, >>ensembl>>transcript) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Etranscript
- map(ENSG00000188389, >>ensembl>>uniprot) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Euniprot
- map(HGNC:8760, >>hgnc>>refseq) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Erefseq
- map(HGNC:8760, >>hgnc>>ccds) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Eccds
- map(ENST00000334409, >>transcript>>exon) https://sugi.bio/biobtree/api/map?i=ENST00000334409&m=%3E%3Etranscript%3E%3Eexon
- entry(Q15116, uniprot) https://sugi.bio/biobtree/api/entry?i=Q15116&s=uniprot
- map(Q15116, >>uniprot>>interpro) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Einterpro
- map(Q15116, >>uniprot>>pdb) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Epdb
- map(Q15116, >>uniprot>>alphafold) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Ealphafold
- map(ENSG00000188389, >>ensembl>>ortholog) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Eortholog
- map(Q15116, >>uniprot>>go) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Ego
- map(ENSG00000188389, >>ensembl>>reactome) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Ereactome
- map(Q15116, >>uniprot>>string_interaction) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Estring_interaction
- map(HGNC:8760, >>hgnc>>clinvar) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Eclinvar
- map(HGNC:8760, >>hgnc>>spliceai) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Espliceai
- map(Q15116, >>uniprot>>alphamissense) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Ealphamissense
- map(Q15116, >>uniprot>>chembl_target) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Echembl_target
- map(Q15116, >>uniprot>>intact) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Eintact
- map(ENSG00000188389, >>ensembl>>bgee) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Ebgee
- map(ENSG00000188389, >>ensembl>>bgee>>bgee_evidence) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Ebgee%3E%3Ebgee_evidence
- map(HGNC:8760, >>hgnc>>hpo) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Ehpo
- map(HGNC:8760, >>hgnc>>gwas) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Egwas
- map(HGNC:8760, >>hgnc>>collectri) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Ecollectri
- map(Q15116, >>uniprot>>esm2_similarity) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Eesm2_similarity
- map(Q15116, >>uniprot>>diamond_similarity) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Ediamond_similarity
- map(CHEMBL3307223, >>chembl_target>>chembl_molecule) https://sugi.bio/biobtree/api/map?i=CHEMBL3307223&m=%3E%3Echembl_target%3E%3Echembl_molecule
- map(HGNC:8760, >>hgnc>>gencc) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Egencc
- map(HGNC:8760, >>hgnc>>pharmgkb_gene) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Epharmgkb_gene
- map(HGNC:8760, >>hgnc>>msigdb) https://sugi.bio/biobtree/api/map?i=HGNC%3A8760&m=%3E%3Ehgnc%3E%3Emsigdb
- entry(CHEMBL3307223, chembl_target) https://sugi.bio/biobtree/api/entry?i=CHEMBL3307223&s=chembl_target
- search(nivolumab, chembl_molecule) https://sugi.bio/biobtree/api/search?i=nivolumab&s=chembl_molecule
- search(pembrolizumab, chembl_molecule) https://sugi.bio/biobtree/api/search?i=pembrolizumab&s=chembl_molecule
- map(ENSG00000188389, >>ensembl>>scxa) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Escxa
- map(ENSG00000188389, >>ensembl>>orphanet) https://sugi.bio/biobtree/api/map?i=ENSG00000188389&m=%3E%3Eensembl%3E%3Eorphanet
- map(Q15116, >>uniprot>>signor) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Esignor
- map(Q15116, >>uniprot>>cellphonedb) https://sugi.bio/biobtree/api/map?i=Q15116&m=%3E%3Euniprot%3E%3Ecellphonedb
- entry(CHEMBL2108738, chembl_molecule) https://sugi.bio/biobtree/api/entry?i=CHEMBL2108738&s=chembl_molecule
- entry(CHEMBL3137343, chembl_molecule) https://sugi.bio/biobtree/api/entry?i=CHEMBL3137343&s=chembl_molecule
- search(cemiplimab, chembl_molecule) https://sugi.bio/biobtree/api/search?i=cemiplimab&s=chembl_molecule
- search(dostarlimab, chembl_molecule) https://sugi.bio/biobtree/api/search?i=dostarlimab&s=chembl_molecule
- search(toripalimab, chembl_molecule) https://sugi.bio/biobtree/api/search?i=toripalimab&s=chembl_molecule
PDCD1 (PD-1) - Comprehensive Cross-Database Identifier and Functional Mapping Reference
Section 1: Gene Identifiers
| Attribute | Value |
|---|---|
| Gene Symbol | PDCD1 |
| Gene Name | Programmed cell death 1 |
| HGNC ID | HGNC:8760 |
| Ensembl Gene ID | ENSG00000188389 |
| NCBI Entrez Gene ID | 5133 |
| OMIM ID | 600244 |
| Locus Type | Protein-coding gene |
| Status | Approved |
| Attribute | Value |
|---|---|
| Chromosome | 2 |
| Cytogenetic Band | 2q37.3 |
| Start Position | 241,849,884 |
| End Position | 241,858,894 |
| Strand | Minus (-) |
| Genome Assembly | GRCh38 |
Section 2: Transcript Identifiers Total Ensembl Transcripts: 7 All Ensembl Transcripts
| Transcript ID | Biotype | Start | End |
|---|---|---|---|
| ENST00000334409 | protein_coding | 241,849,884 | 241,858,894 |
| ENST00000343705 | protein_coding | 241,849,884 | 241,858,894 |
| ENST00000718473 | protein_coding | 241,849,884 | 241,858,894 |
| ENST00000890793 | protein_coding | 241,849,886 | 241,858,894 |
| ENST00000944235 | protein_coding | 241,849,887 | 241,858,894 |
| ENST00000418831 | nonsense_mediated_decay | 241,850,697 | 241,858,865 |
| ENST00000718474 | nonsense_mediated_decay | 241,849,884 | 241,858,894 |
| RefSeq ID | Type | Status | MANE Select |
|---|---|---|---|
| NM_005018 | mRNA | REVIEWED | ✓ Yes |
| XM_006712573 | mRNA | PREDICTED | No |
| XM_054328654 | mRNA | PREDICTED | No |
| XM_054342460 | mRNA | PREDICTED | No |
| CCDS ID |
|---|
| CCDS33428 |
| Exon ID | Start | End | Strand |
|---|---|---|---|
| ENSE00001372954 | 241,858,763 | 241,858,894 | - |
| ENSE00001384908 | 241,852,621 | 241,852,980 | - |
| ENSE00003549266 | 241,851,949 | 241,851,983 | - |
| ENSE00003605706 | 241,852,198 | 241,852,353 | - |
| ENSE00004035194 | 241,849,884 | 241,851,297 | - |
Section 3: Protein Identifiers UniProt Accessions
| UniProt ID | Status | Name |
|---|---|---|
| Q15116 | ✓ Reviewed (Swiss-Prot) | Programmed cell death protein 1 |
| A0A0M3M0G7 | Unreviewed (TrEMBL) | - |
| E7ER21 | Unreviewed (TrEMBL) | - |
| H0Y2W6 | Unreviewed (TrEMBL) | - |
| Property | Value |
|---|---|
| Length | 288 amino acids |
| Mass | 31,647 Da |
| RefSeq ID | Type | Status |
|---|---|---|
| NP_005009 | protein | REVIEWED |
| XP_006712636 | predicted_protein | PREDICTED |
| XP_054184629 | predicted_protein | PREDICTED |
| XP_054198435 | predicted_protein | PREDICTED |
| InterPro ID | Name | Type |
|---|---|---|
| IPR003599 | Ig_sub | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013106 | Ig_V-set | Domain |
| IPR042379 | PDCD1 | Family |
| IPR013783 | Ig-like_fold | Homologous superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous superfamily |
Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB Structure Count: 37
| PDB ID | Title | Method | Resolution (Å) |
|---|---|---|---|
| 2M2D | Human PD-1 receptor | SOLUTION NMR | - |
| 3RRQ | Extracellular domain of human PD-1 | X-RAY DIFFRACTION | 2.1 |
| 4ZQK | PD-1/PD-L1 complex | X-RAY DIFFRACTION | 2.45 |
| 5B8C | PD-1 with pembrolizumab Fv | X-RAY DIFFRACTION | 2.15 |
| 5GGR | PD-1 with nivolumab Fab | X-RAY DIFFRACTION | 3.3 |
| 5GGS | PD-1 with pembrolizumab Fab | X-RAY DIFFRACTION | 2.0 |
| 5IUS | PD-L1 with PD-1 mutant | X-RAY DIFFRACTION | 2.89 |
| 5JXE | PD-1 with Pembrolizumab Fab | X-RAY DIFFRACTION | 2.9 |
| 5WT9 | PD-1 with nivolumab-Fab | X-RAY DIFFRACTION | 2.4 |
| 6HIG | PD-1/NBO1a Fab complex | X-RAY DIFFRACTION | 2.2 |
| 6J14 | PD-1 with GY-14 | X-RAY DIFFRACTION | 1.4 |
| 6J15 | PD-1 with GY-5 Fab | X-RAY DIFFRACTION | 2.6 |
| 6JBT | PD-1 with toripalimab-Fab | X-RAY DIFFRACTION | 2.47 |
| 6JJP | PD-1 with MW11-h317 antibody | X-RAY DIFFRACTION | 2.9 |
| 6K0Y | PD-1 with mAb059c | X-RAY DIFFRACTION | 1.7 |
| 6R5G | SHP-2 with PD-1 phospho-ITSM | SOLUTION NMR | - |
| 6ROY | N-SH2/PTPN11 with ITIM | X-RAY DIFFRACTION | 2.1 |
| 6ROZ | N-SH2/PTPN11 with ITSM | X-RAY DIFFRACTION | 2.89 |
| 6UMT | PD-1/PD-L2 complex | X-RAY DIFFRACTION | 1.99 |
| 6UMU | Apo PD-1 triple mutant | X-RAY DIFFRACTION | 1.18 |
| 6UMV | Apo PD-1 double mutant | X-RAY DIFFRACTION | 1.42 |
| 6XKR | PD-1 with Sasanlimab Fab | X-RAY DIFFRACTION | 2.59 |
| 7BXA | PD-1 with tislelizumab Fab | X-RAY DIFFRACTION | 3.32 |
| 7CGW | PD-1 with tislelizumab Fab | X-RAY DIFFRACTION | 3.2 |
| 7CU5 | PD-1 with camrelizumab | X-RAY DIFFRACTION | 2.81 |
| 7E9B | PD-1 with HLX10 antibody | X-RAY DIFFRACTION | 1.78 |
| 7VUX | PD-1 with 609A-Fab | X-RAY DIFFRACTION | 1.64 |
| 7WSL | PD-1 with Dostarlimab | X-RAY DIFFRACTION | 1.53 |
| 7WVM | PD-1 with cemiplimab | X-RAY DIFFRACTION | 3.4 |
| 8AS0 | PD-1 with D12 antibody Fab | X-RAY DIFFRACTION | 3.5 |
| 8EQ6 | PD-1 with Fab Complex | X-RAY DIFFRACTION | 1.65 |
| 8GY5 | PD-1 with cemiplimab Fab | X-RAY DIFFRACTION | 1.98 |
| 8U31 | PD-1 with Fab | X-RAY DIFFRACTION | 2.73 |
| 8U32 | PD-1 with Fab | X-RAY DIFFRACTION | 2.51 |
| 9HK1 | PD-1 with Fab Complex | X-RAY DIFFRACTION | 2.03 |
| 9Q8L | PD-1 with 21A08Ap1-Fab | X-RAY DIFFRACTION | 1.85 |
| 9EHT | PD-1 with retifanlimab | X-RAY DIFFRACTION | 1.54 |
| AlphaFold ID | Global pLDDT | Sequence Length | Fraction Very High pLDDT |
|---|---|---|---|
| Q15116 | 74.53 | 2232 | 0.36 |
Section 5: Cross-Species Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|---|---|---|
| Mouse (Mus musculus) | ENSMUSG00000026285 | Pdcd1 | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000019043 | Pdcd1 | protein_coding |
| Zebrafish (Danio rerio) | No data available | - | - |
| Fruit fly (D. melanogaster) | No data available | - | - |
| Worm (C. elegans) | No data available | - | - |
| Yeast (S. cerevisiae) | No data available | - | - |
Section 6: Clinical Variants & AI Predictions ClinVar Variant Summary Total Variant Count: 48
| Classification | Count |
|---|---|
| Pathogenic | 1 |
| Likely Pathogenic | 0 |
| Uncertain Significance (VUS) | 14 |
| Likely Benign | 6 |
| Benign | 16 |
| Not Classified | 11 |
| ClinVar ID | HGVS | Classification | Condition |
|---|---|---|---|
| 3376502 | PDCD1, 1-BP DUP, 105C | Pathogenic | - |
| ClinVar ID | HGVS Notation | Classification |
|---|---|---|
| 2243463 | c.38C>T (p.Ala13Val) | VUS |
| 2333454 | c.347A>T (p.Asn116Ile) | VUS |
| 2372384 | c.31G>A (p.Val11Ile) | VUS |
| 2398088 | c.581G>A (p.Arg194Gln) | VUS |
| 2531224 | c.344G>A (p.Arg115His) | VUS |
| 3210522 | c.633G>T (p.Glu211Asp) | VUS |
| 3305293 | c.416G>A (p.Arg139Gln) | VUS |
| 3887101 | c.328G>A (p.Val110Met) | VUS |
| 3929843 | c.512T>C (p.Val171Ala) | VUS |
| 4133549 | c.526G>T (p.Gly176Cys) | VUS |
| 4566153 | c.854C>T (p.Ser285Phe) | VUS |
| 4566154 | c.415C>T (p.Arg139Trp) | VUS |
| 4566155 | c.256C>T (p.Arg86Cys) | VUS |
| Variant | Effect | Delta Score |
|---|---|---|
| 2:241851295:CTT:C | acceptor_gain | 1.00 |
| 2:241851298:C:CC | acceptor_gain | 1.00 |
| 2:241851299:T:C | acceptor_gain | 1.00 |
| 2:241851300:T:C | acceptor_gain | 1.00 |
| 2:241851300:T:TC | acceptor_gain | 1.00 |
| 2:241851944:CTCA:C | donor_loss | 1.00 |
| 2:241851945:TCA:T | donor_loss | 1.00 |
| 2:241851291:CCTCC:C | acceptor_gain | 0.98 |
| 2:241851292:CTCC:C | acceptor_gain | 0.98 |
| 2:241851293:TCCT:T | acceptor_gain | 0.98 |
| 2:241851948:CCA:C | donor_gain | 0.98 |
| 2:241851262:C:CT | acceptor_gain | 0.97 |
| 2:241851290:TCCTC:T | acceptor_gain | 0.97 |
| 2:241851291:CCTC:C | acceptor_gain | 0.98 |
| 2:241851292:CTCCT:C | acceptor_loss | 0.96 |
| 2:241851293:TCC:T | acceptor_loss | 0.96 |
| 2:241851294:CC:C | acceptor_loss | 0.96 |
| 2:241851295:C:CC | acceptor_loss | 0.96 |
| 2:241851295:CTTCT:C | acceptor_loss | 0.99 |
| 2:241851296:TT:T | acceptor_gain | 0.99 |
| 2:241851297:TC:T | acceptor_loss | 0.99 |
| 2:241851298:C:CG | acceptor_loss | 0.99 |
| 2:241851299:T:A | acceptor_loss | 0.99 |
| 2:241851299:T:TC | acceptor_gain | 0.99 |
| 2:241851943:ACTC:A | donor_loss | 0.99 |
| 2:241851947:A:AC | donor_gain | 0.99 |
| 2:241851947:AC:A | donor_gain | 0.96 |
| 2:241851948:C:CC | donor_gain | 0.99 |
| 2:241851948:CC:C | donor_gain | 0.96 |
| 2:241851293:TCCTT:T | acceptor_gain | 0.99 |
| 2:241851294:CCTTC:C | acceptor_gain | 0.99 |
| Variant ID | Protein Change | AM Score | AM Class |
|---|---|---|---|
| 2:241851067:C:A | W286C | 0.920 | likely_pathogenic |
| 2:241851067:C:G | W286C | 0.920 | likely_pathogenic |
| 2:241851069:A:G | W286R | 0.903 | likely_pathogenic |
| 2:241851069:A:T | W286R | 0.903 | likely_pathogenic |
| 2:241851062:A:T | L288H | 0.663 | likely_pathogenic |
| 2:241851068:C:A | W286L | 0.613 | likely_pathogenic |
| 2:241851068:C:G | W286S | 0.602 | likely_pathogenic |
Section 7: Biological Pathways & Gene Ontology Reactome Pathways Total Pathway Count: 3
| Pathway ID | Pathway Name | Disease Pathway |
|---|---|---|
| R-HSA-389948 | Co-inhibition by PD-1 | No |
| R-HSA-9679191 | Potential therapeutics for SARS | Yes |
| R-HSA-9931295 | PD-L1 glycosylation and translocation to plasma membrane | No |
| GO ID | Term Name |
|---|---|
| GO:0001783 | B cell apoptotic process |
| GO:0002250 | adaptive immune response |
| GO:0002644 | negative regulation of tolerance induction |
| GO:0002841 | negative regulation of T cell mediated immune response to tumor cell |
| GO:0002903 | negative regulation of B cell apoptotic process |
| GO:0006915 | apoptotic process |
| GO:0006959 | humoral immune response |
| GO:0050728 | negative regulation of inflammatory response |
| GO:0050776 | regulation of immune response |
| GO:0050777 | negative regulation of immune response |
| GO:0050860 | negative regulation of T cell receptor signaling pathway |
| GO:0050868 | negative regulation of T cell activation |
| GO:0070234 | positive regulation of T cell apoptotic process |
| GO:1902482 | regulatory T cell apoptotic process |
| GO ID | Term Name |
|---|---|
| GO:0004888 | transmembrane signaling receptor activity |
| GO:0038023 | signaling receptor activity |
| GO ID | Term Name |
|---|---|
| GO:0005886 | plasma membrane |
| GO:0009897 | external side of plasma membrane |
- REACTOME_CO_INHIBITION_BY_PD_1
- GOBP_NEGATIVE_REGULATION_OF_T_CELL_ACTIVATION
- GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE
- GOBP_ADAPTIVE_IMMUNE_RESPONSE
- KEGG_CELL_ADHESION_MOLECULES_CAMS
Section 8: Protein Interactions & Molecular Networks STRING Protein-Protein Interactions Total STRING Interaction Count: 2,840 TOP 50 Highest-Confidence Interacting Proteins:
| UniProt ID | Gene Symbol | Score |
|---|---|---|
| Q9BQ51 | PDCD1LG2 (PD-L2) | 999 |
| Q9NZQ7 | CD274 (PD-L1) | 999 |
| P33681 | CD80 | 997 |
| P42081 | CD86 | 996 |
| P16410 | CTLA4 | 990 |
| Q06124 | PTPN11 (SHP-2) | 973 |
| O00182 | LGALS9 | 968 |
| Q3B8N2 | - | 947 |
| Q6DKI2 | - | 947 |
| P18627 | LAG3 | 930 |
| P01732 | CD8A | 929 |
| P10747 | CD80 | 929 |
| Q9Y6W8 | - | 929 |
| P01730 | CD4 | 920 |
| Q5JR59 | - | 884 |
| Q7Z6A9 | - | 884 |
| Q9ULD2 | - | 884 |
| O75144 | ICOSLG | 883 |
| P15151 | PVR | 883 |
| Partner Gene | Interaction Type | Confidence |
|---|---|---|
| CD274 (PD-L1) | direct interaction | 0.890 |
| PDCD1LG2 (PD-L2) | direct interaction | 0.850 |
| PTPN11 (SHP-2) | physical association | 0.600 |
| CD80 | direct interaction | 0.440 |
| AP2B1 | direct interaction | 0.440 |
| AKT1 | physical association | 0.470 |
| CEACAM1 | physical association | 0.400 |
| PTPN6 (SHP-1) | association | 0.350 |
| Entity A | Entity B | Effect | Mechanism |
|---|---|---|---|
| CD274 | PDCD1 | up-regulates | binding |
| nivolumab | PDCD1 | down-regulates activity | binding |
| pembrolizumab | PDCD1 | down-regulates activity | binding |
| PTPN11 | PDCD1 | down-regulates activity | dephosphorylation |
| CDK1 | PDCD1 | down-regulates quantity | phosphorylation |
| SCF-FBW7 | PDCD1 | down-regulates quantity | polyubiquitination |
| hsa-miR-138-5p | PDCD1 | down-regulates quantity | post-transcriptional |
| PDCD1 | AKT | down-regulates activity | - |
| PDCD1 | ERK1/2 | down-regulates activity | - |
| PDCD1 | T cell exhaustion | up-regulates | - |
| Partner A | Partner B | Directionality |
|---|---|---|
| PDCD1LG2 | PDCD1 | Ligand-Receptor |
| CD274 | PDCD1 | Ligand-Receptor |
| UniProt ID | Top Similarity | Avg Similarity |
|---|---|---|
| Q9Y3P8 | 0.9970 | 0.9548 |
| Q0V881 | 0.9964 | 0.9006 |
| Q5SQ64 | 0.9964 | 0.9082 |
| Q99NH8 | 0.9936 | 0.9517 |
| Q9NZC2 | 0.9936 | 0.9435 |
| UniProt ID | Top Identity (%) | Bitscore |
|---|---|---|
| Q02242 | 59.30 | 329.00 |
Section 9: Transcription Factor Regulatory Data Note: PDCD1 encodes a cell surface receptor, not a transcription factor. It does not have downstream transcriptional targets. Upstream Regulators (TFs that regulate PDCD1) Source: CollecTRI Database
| TF Gene | Target Gene | Confidence |
|---|---|---|
| RBPJ | PDCD1 | High |
| IRF9 | PDCD1 | Low |
| NFATC1 | PDCD1 | Low |
| TBX21 | PDCD1 | Low |
Section 10: Drug & Pharmacology Data ChEMBL Target Information
| ChEMBL ID | Target Name | Type | Mechanism |
|---|---|---|---|
| CHEMBL3307223 | Programmed cell death protein 1 | SINGLE PROTEIN | PD-1 inhibitor |
| CHEMBL4523993 | PD-1/PD-L1 complex | PROTEIN COMPLEX | - |
| CHEMBL5482985 | PD-1/PD-L2 | PROTEIN COMPLEX | - |
| ChEMBL ID | Drug Name | Trade Name | Type | ATC Code |
|---|---|---|---|---|
| CHEMBL2108738 | Nivolumab | Opdivo | Antibody | L01FF01 |
| CHEMBL3137343 | Pembrolizumab | Keytruda | Antibody | L01FF02 |
| CHEMBL4297723 | Cemiplimab | Libtayo | Antibody | - |
| CHEMBL4298124 | Dostarlimab | Jemperli | Antibody | - |
| CHEMBL4297843 | Toripalimab | - | Antibody | - |
| Drug | Clinical Trial Count |
|---|---|
| Nivolumab | 1,522 |
| Pembrolizumab | 2,214 |
| Cemiplimab | 261 |
| Dostarlimab | 150 |
| Toripalimab | 479 |
Melanoma
Non-small cell lung cancer (NSCLC)
Renal cell carcinoma
Hodgkin lymphoma
Head and neck squamous cell carcinoma
Urothelial carcinoma
Colorectal cancer (MSI-H/dMMR)
Hepatocellular carcinoma
Esophageal cancer
Gastric cancer Pembrolizumab:
Melanoma
Non-small cell lung cancer
Head and neck squamous cell carcinoma
Hodgkin lymphoma
Primary mediastinal B-cell lymphoma
Urothelial carcinoma
MSI-H/dMMR cancers
Gastric cancer
Cervical cancer
Hepatocellular carcinoma
Merkel cell carcinoma
Renal cell carcinoma
Endometrial cancer
Triple-negative breast cancer PharmGKB
| PharmGKB ID | Symbol | VIP Gene | CPIC Guideline |
|---|---|---|---|
| PA33110 | PDCD1 | Yes | No |
Section 11: Expression Profiles Bgee Expression Summary
| Property | Value |
|---|---|
| Expression Pattern | Ubiquitous |
| Total Present Calls | 114 |
| Max Expression Score | 85.78 |
| Rank | Tissue | Expression Score | Quality |
|---|---|---|---|
| 1 | Lymph node | 85.78 | gold |
| 2 | Granulocyte | 78.92 | gold |
| 3 | Spleen | 75.99 | gold |
| 4 | Right atrium auricular region | 74.95 | gold |
| 5 | Vermiform appendix | 74.67 | gold |
| 6 | Blood | 74.23 | gold |
| 7 | Small intestine Peyer's patch | 66.51 | gold |
| 8 | Heart | 65.48 | gold |
| 9 | Small intestine | 65.43 | gold |
| 10 | Heart left ventricle | 65.13 | gold |
| 11 | Transverse colon mucosa | 65.01 | gold |
| 12 | Upper lobe of left lung | 64.62 | gold |
| 13 | Tonsil | 63.71 | gold |
| 14 | Bone marrow | 63.35 | gold |
| 15 | Omental fat pad | 62.81 | gold |
| 16 | Fundus of stomach | 61.50 | gold |
| 17 | Body of stomach | 61.39 | gold |
| 18 | Gall bladder | 60.40 | gold |
| 19 | Adipose tissue | 60.20 | gold |
| 20 | Endocervix | 60.11 | gold |
| 21 | Pituitary gland | 59.68 | gold |
| 22 | Left uterine tube | 59.15 | gold |
| 23 | Stomach | 58.58 | gold |
| 24 | Lung | 58.49 | gold |
| 25 | Subcutaneous adipose tissue | 58.18 | gold |
| 26 | Salivary gland | 58.08 | gold |
| 27 | Adenohypophysis | 57.91 | gold |
| 28 | Left thyroid lobe | 57.80 | gold |
| 29 | Stomach mucosa | 57.72 | gold |
| 30 | Minor salivary gland | 57.66 | gold |
| Experiment ID | Description | Cells |
|---|---|---|
| E-HCAD-29 | GM-CSF-producing T helper cells study | 78,686 |
| E-MTAB-8911 | mTOR mutation in T cells / Chronic GVHD | 19,075 |
Section 12: Disease Associations GenCC Disease-Gene Association
| Disease | Classification | Mode of Inheritance | Source |
|---|---|---|---|
| Systemic lupus erythematosus | Supportive | Unknown | Orphanet |
| Orphanet ID | Disease Name | Type | Associated Genes |
|---|---|---|---|
| 536 | Systemic lupus erythematosus | Disease | 30 genes |
| Study ID | Disease/Trait | Mapped Region | P-value |
|---|---|---|---|
| GCST003044_162 | Crohn's disease | GAL3ST2 region | 1.0×10⁻⁹ |
| GCST90002381_388 | Eosinophil count | NEU4-PDCD1 | 5.0×10⁻¹⁰ |
| GCST90002382_194 | Eosinophil percentage | NEU4-PDCD1 | 1.0×10⁻¹¹ |
| HPO ID | Phenotype Term |
|---|---|
| HP:0100651 | Type I diabetes mellitus |
| HP:0033726 | Lupus nephritis |
| HP:0002958 | Immune dysregulation |
| HP:0000821 | Hypothyroidism |
| HP:0001878 | Hemolytic anemia |
| HP:0001873 | Thrombocytopenia |
| HP:0025300 | Malar rash |
| HP:0001369 | Arthritis |
| HP:0001945 | Fever |
| HP:0012378 | Fatigue |
| HP:0002716 | Lymphadenopathy |
| HP:0001744 | Splenomegaly |
| HP:0002240 | Hepatomegaly |
| HP:0000093 | Proteinuria |
| HP:0001596 | Alopecia |
| HP:0003493 | Antinuclear antibody positivity |
| HP:0020151 | Anti-dsDNA antibody positivity |
| HP:0034062 | Anti-insulin antibody positivity |
| HP:0034063 | Anti-islet antigen-2 antibody positivity |
| HP:0000488 | Retinopathy |
Summary Statistics
| Category | Count |
|---|---|
| Gene Identifiers | 5 databases |
| Transcripts (Ensembl) | 7 |
| Transcripts (RefSeq, human) | 4 |
| UniProt Entries | 4 |
| Protein Domains/Families | 6 |
| PDB Structures | 37 |
| Orthologs (mammals) | 2 |
| ClinVar Variants | 48 |
| SpliceAI Predictions | 688 |
| AlphaMissense Predictions | 1,846 |
| GO Terms | 18 |
| Reactome Pathways | 3 |
| STRING Interactions | 2,840 |
| IntAct Interactions | 58 |
| SIGNOR Interactions | 12 |
| Approved Drugs | 5+ |
| Clinical Trials | 4,500+ |
| Expression Tissues | 114+ |
| HPO Phenotypes | 68 |
| GWAS Associations | 3 |
This reference document was compiled from BioBTree integrated database queries across HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, AlphaMissense, SpliceAI, Reactome, GO, STRING, IntAct, SIGNOR, ChEMBL, PharmGKB, Bgee, SCXA, Orphanet, GenCC, HPO, and GWAS Catalog. I’ve compiled a comprehensive cross-database identifier and functional mapping reference for PDCD1 (PD-1). Key highlights: Gene Identifiers: HGNC:8760, ENSG00000188389, Entrez 5133, OMIM 600244, located at chr2:241,849,884-241,858,894 (minus strand) Transcripts: 7 Ensembl transcripts (5 protein-coding), MANE Select is NM_005018, CCDS33428 Protein: Canonical UniProt Q15116 (288 aa, 31.6 kDa) with Ig V-set domain (IPR013106) Structures: 37 PDB structures including complexes with all major anti-PD-1 antibodies (nivolumab, pembrolizumab, cemiplimab, dostarlimab, toripalimab, tislelizumab, camrelizumab) Clinical Variants: 48 ClinVar entries (1 pathogenic, 14 VUS); 688 SpliceAI predictions; 1,846 AlphaMissense predictions Interactions: Key partners are PD-L1 (CD274), PD-L2 (PDCD1LG2), PTPN11 (SHP-2); 2,840 STRING interactions Drug Data: 5+ approved anti-PD-1 antibodies with 4,500+ clinical trials; target for cancer immunotherapy Expression: Highest in lymphoid tissues (lymph node, spleen, blood) - consistent with T cell checkpoint function Disease Links: Systemic lupus erythematosus (GenCC/Orphanet); GWAS links to Crohn’s disease and eosinophil counts